申请人:PROLUME, LTD.
公开号:US11034886B2
公开(公告)日:2021-06-15
Novel compounds in the classes of Imidazo[1,2-α]pyrazines and Imidazo[1,2-α]quinoxalines with a methoxy group modification show unique spectral properties when used as a substrate for luciferases and photo-proteins. Methoxy e-Coelenterazine, an Imidazo[1,2-α] quinoxaline shifts the emission wavelength by 80 nm to blue light compared to e-Coelenterazine, using Renilla reniformis luciferase. The novel analogues described here are useful in combination with fluorescent proteins to create BRET (bioluminescent resonance energy transfer) and for other luminescent assays. In addition these novel compounds can be used to enhance, dazzle, amaze, startle, and otherwise entertain an audience by their direct application on to the audience, surroundings, the actors, or sprayed on settings as in the newer 4D movies.
带有甲氧基修饰的咪唑并[1,2-α]吡嗪类和咪唑并[1,2-α]喹喔啉类新化合物在用作荧光素酶和光蛋白的底物时显示出独特的光谱特性。与 e-Coelenterazine 相比,甲氧基 e-Coelenterazine(一种咪唑并[1,2-α]喹喔啉)能使雷尼拉肾形荧光素酶的发射波长向蓝光移动 80 纳米。这里介绍的新型类似物可与荧光蛋白结合,用于产生 BRET(生物发光共振能量转移)和其他发光检测。此外,这些新型化合物还可直接作用于观众、周围环境、演员,或喷洒在较新的 4D 电影中的场景上,从而增强、炫目、惊奇、惊吓或以其他方式娱乐观众。